An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway

SIMPLE SUMMARY: It has been a continuous effort to develop innovative targeted cancer treatments to overcome the non-specific toxicity associated with chemotherapy. Antibody-drug conjugates (ADCs) highlight the clinical benefits of specifically delivering drugs to cancer cells via targeting agents....

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Xirui, Yu, Haixiang, Sullenger, Cynthia, Gray, Bethany Powell, Yan, Amy, Kelly, Linsley, Sullenger, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136559/
https://www.ncbi.nlm.nih.gov/pubmed/37190227
http://dx.doi.org/10.3390/cancers15082301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136559/
https://www.ncbi.nlm.nih.gov/pubmed/37190227
http://dx.doi.org/10.3390/cancers15082301

Ejemplares similares